Literature DB >> 16491404

Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.

T Negele1, G Meisetschläger, T Brückner, K Scheidhauer, M Schwaiger, H Vogelsang.   

Abstract

BACKGROUND AND AIMS: Persistent differentiated papillary thyroid cancer following radical locoregional surgery with metastases is an indication for limited reoperation or radioiodine therapy. Following injection of radioiodine, radio-guided surgery with application of an intraoperative gamma probe offers detection of metastases not seen by conventional imaging and control of completeness of resection. PATIENTS/
METHODS: We demonstrate four patients with locoregional metastases, two of them with additional distant metastases of papillary thyroid cancer following radical neck surgery. Postoperative radioiodine scans demonstrated persistent ipsilateral or contralateral cervical and mediastinal lymph node and isolated rib metastases.
RESULTS: Radio-guided surgery (RGS) leads to complete clearance of persistent lymph node metastases by limited recurrent neck surgery, resection of metastases not seen by conventional imaging and control of complete mediastinal lymph node dissection. Post-RGS scans allowed early diagnosis of occult diffuse or nodal pulmonary metastases in two patients. At last follow-up, 23 to 48 months following RGS and radioiodine therapy, there was no evidence of disease.
CONCLUSIONS: Radio-guided surgery is an additive surgical technique with low morbidity in selected patients with persistent thyroid cancer individualizing tumor therapy options in multimode oncological therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491404     DOI: 10.1007/s00423-005-0013-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  23 in total

1.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors:  R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal:  Endocr Pract       Date:  2001 May-Jun       Impact factor: 3.443

2.  Radioiodine in treatment of metastatic thyroid cancer.

Authors:  S S Dewan; S M Sharma; R D Ganatra
Journal:  Int J Nucl Med Biol       Date:  1979

3.  Current results of treatment for distant metastatic well-differentiated thyroid carcinoma.

Authors:  W J Wood; S E Singletary; R C Hickey
Journal:  Arch Surg       Date:  1989-12

4.  The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.

Authors:  R W Tsang; J D Brierley; W J Simpson; T Panzarella; M K Gospodarowicz; S B Sutcliffe
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

5.  Surgical reintervention for differentiated thyroid cancer.

Authors:  P E Goretzki; D Simon; A Frilling; J Witte; C Reiners; M Grussendorf; F A Horster; H D Röher
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

6.  Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)

Authors:  M Coburn; D Teates; H J Wanebo
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

7.  Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer.

Authors:  Massimo Salvatori; Vittoria Rufini; Francesca Reale; Ana Maria Samanes Gajate; Maria Lodovica Maussier; Luca Revelli; Luigi Troncone; Guglielmo Ardito
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

8.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

9.  Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.

Authors:  F Pacini; F Cetani; P Miccoli; F Mancusi; C Ceccarelli; F Lippi; E Martino; A Pinchera
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer.

Authors:  F Lippi; M Capezzone; P Miccoli; C Traino; F Di Martino; F Angelini; C Spinelli; P Iacconi; A Pinchera; F Pacini
Journal:  Tumori       Date:  2000 Jul-Aug
View more
  2 in total

1.  Localization of recurrent thyroid cancer using intraoperative ultrasound-guided dye injection.

Authors:  Rebecca S Sippel; Dina M Elaraj; Liina Poder; Quan-Yang Duh; Electron Kebebew; Orlo H Clark
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 2.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.